Int. Journal of Clinical Pharmacology and Therapeutics, Volume 61 (2023) - December (551 - 560)

Porcine antilymphocyte globulin versus rabbit antithymocyte globulin for intensive immunosuppressive therapy of acquired aplastic anemia: A meta-analysis and systematic review

Jinsong Jia, Shasha Wang, Ying Kang, Xiujuan Liu, Lanping Xu
Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China

Add to Cart    

 

DOI 10.5414/CP204379

Abstract

Objective: Several studies have reported that porcine antilymphocyte globulin (pALG) has a significant effect on aplastic anemia (AA), but their conclusions are inconsistent. To objectively evaluate its efficacy and safety, a meta-analysis was conducted.
Materials and methods: We systematically searched the relevant literature on pALG vs. rabbit antithymocyte globulin (rATG) as the first-line treatment in AA patients until August 31, 2022, in electronic databases: PubMed, Cochrane Library, Web of Science, etc. Two researchers independently extracted data and evaluated the quality of the study. Stata 14.0 was used for statistical analysis.
Results: 50 studies were included in the analysis. The overall responses at 3, 6, and 12 months between the pALG group and rATG group were equivalent. We analyzed early mortality, total mortality, relapse rates, and 5-year survival after the administration of pALG or rATG, and there was no significant difference between the pALG and rATG groups. In our study, the incidence of infection in the pALG group was better than that in the rATG group, OR = 0.63, 95% CI (0.44 – 0.88), p = 0.008, which showed a statistically significant difference.
Conclusion: The efficacy of pALG in AA patients is equivalent to that of rATG. rATG was associated with a significantly higher incidence rate of infection than pALG.

Author Details

Authors

Departments

  • Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China

Address

Jinsong Jia
Peking University People’s Hospital
Peking University Institute of Hematology
National Clinical Research Center for Hematologic Disease
No. 11 Xizhimen South Street, Beijing, 100044, China
Email: [email protected]

Log in for Subscribers

Citation

Jinsong Jia, Shasha Wang, Ying Kang, Xiujuan Liu, Lanping Xu. Porcine antilymphocyte globulin versus rabbit antithymocyte globulin for intensive immunosuppressive therapy of acquired aplastic anemia: A meta-analysis and systematic review
. Int J Clin Pharmacol Ther. 2023; 61: 551-560. doi: 10.5414/CP204379. Pubmed: https://pubmed.ncbi.nlm.nih.gov/37877292/; PMID: 37877292.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart